Structures by: Karrouchi K.
Total: 26
Ethyl 2-[(5<i>Z</i>)-5-(4-methoxybenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]acetate
C15H15NO5S
IUCrData (2016) 1, 7 x161041
a=6.1957(2)Å b=10.6460(3)Å c=12.2909(3)Å
α=68.8450(10)° β=78.9710(10)° γ=84.9190(10)°
5-Methyl-<i>N</i>'-[(<i>Z</i>)-4-methylbenzylidene]-1<i>H</i>-pyrazole-3-carbohydrazide
C13H14N4O
IUCrData (2016) 1, 5 x160793
a=6.32830(10)Å b=19.6204(4)Å c=10.1245(2)Å
α=90° β=105.7460(10)° γ=90°
<i>N</i>'-[(1<i>E</i>)-4-Bromobenzylidene]-5-phenyl-1<i>H</i>-pyrazole-3-carbohydrazide
C17H13BrN4O
IUCrData (2016) 1, 5 x160830
a=15.5151(3)Å b=7.17520(10)Å c=14.4593(3)Å
α=90° β=110.0720(10)° γ=90°
C16H20Cl2CoN4
C16H20Cl2CoN4
New Journal of Chemistry (2020) 44, 6 2210-2221
a=10.6315(8)Å b=9.9746(5)Å c=16.8984(13)Å
α=90° β=90.076(6)° γ=90°
C16H20Cl2N4Zn
C16H20Cl2N4Zn
New Journal of Chemistry (2020) 44, 6 2210-2221
a=21.6975(12)Å b=8.4668(3)Å c=40.556(2)Å
α=90° β=102.999(4)° γ=90°
C32H42Cl4Co2N8O
C32H42Cl4Co2N8O
New Journal of Chemistry (2020) 44, 6 2210-2221
a=8.7970(15)Å b=11.744(2)Å c=19.603(4)Å
α=77.180(5)° β=82.835(6)° γ=74.748(5)°
2-(2-Oxo-1,3-oxazolidin-3-yl)ethyl 2-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]quinoline-4-carboxylate
C20H21N3O7
Acta Crystallographica Section E (2021) 77, 1 28-33
a=6.0686(5)Å b=19.2791(15)Å c=16.3795(13)Å
α=90° β=94.185(4)° γ=90°
(<i>E</i>)-4-(2,6-Dichlorobenzyl)-6-styrylpyridazin-3(2<i>H</i>)-one
C19H14Cl2N2O
Acta Crystallographica Section E (2021) 77, 1 23-27
a=10.1306(5)Å b=10.7019(6)Å c=15.7749(7)Å
α=90° β=97.715(4)° γ=90°
Hexyl 1-hexyl-2-oxo-1,2-dihydroquinoline-4-carboxylate
C22H31NO3
Acta Crystallographica Section E (2020) 76, 5 642-645
a=17.6928(7)Å b=13.2512(5)Å c=8.5916(3)Å
α=90° β=90.184(2)° γ=90°
2-(5-Benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid
C19H16N2O3
Acta Crystallographica Section E (2020) 76, 3 432-437
a=10.5500(8)Å b=9.3679(6)Å c=16.5606(15)Å
α=90° β=93.886(7)° γ=90°
C19H16N2O3
C19H16N2O3
Acta Crystallographica Section E (2020) 76, 3 432-437
a=10.5976(6)Å b=15.5500(7)Å c=10.3731(7)Å
α=90° β=109.120(5)° γ=90°
2-[5-(4-Methylbenzyl)-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl]acetic acid
C20H18N2O3
Acta Crystallographica Section E (2019) 75, 12 1925-1929
a=8.4213(7)Å b=9.0739(9)Å c=12.2238(12)Å
α=106.501(8)° β=92.390(8)° γ=100.750(8)°
6-[(<i>E</i>)-2-(Thiophen-2-yl)ethenyl]-4,5-dihydropyridazin-3(2<i>H</i>)-one
C10H10N2OS
Acta Crystallographica Section E (2019) 75, 12 1880-1883
a=6.9932(5)Å b=16.2916(9)Å c=9.3544(7)Å
α=90° β=110.168(6)° γ=90°
(<i>E</i>)-6-(4-Hydroxy-3-methoxystyryl)-4,5-dihydropyridazin-3(2<i>H</i>)-\ one
C13H14N2O3
Acta Crystallographica Section E (2019) 75, 11 1734-1737
a=6.0828(9)Å b=9.4246(13)Å c=11.1724(16)Å
α=75.838(11)° β=83.099(12)° γ=84.059(11)°
4-Benzyl-6-phenyl-4,5-dihydropyridazin-3(2<i>H</i>)-one
C17H14N2O
Acta Crystallographica Section E (2019) 75, 11 1679-1684
a=10.819(3)Å b=11.501(3)Å c=11.187(4)Å
α=90° β=90.93(3)° γ=90°
Methyl 2-[5-(2,6-dichlorobenzyl)-6-oxo-3-phenyl-1,4,5,6-tetrahydro-pyridazin-1-yl]acetate
C20H16Cl2N2O3
Acta Crystallographica Section E (2019) 75, 11 1679-1684
a=11.2730(13)Å b=12.3808(9)Å c=14.1405(15)Å
α=90° β=92.801(9)° γ=90°
4-Dichloromethyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-2-one
C10H8Cl2N2O
Acta Crystallographica Section E (2019) 75, 1 33-37
a=12.1783(6)Å b=5.7217(3)Å c=14.8258(7)Å
α=90° β=95.7400(10)° γ=90°
<i>N</i>-{2-[(<i>E</i>)-(4-Methylbenzylidene)amino]phenyl}-2-(5-methyl-1-<i>H</i>-pyrazol-3-yl)acetamide hemihydrate
C20H20N4O,0.5(H2O)
Acta Crystallographica Section E (2019) 75, 2 154-158
a=11.546(3)Å b=12.564(3)Å c=13.172(3)Å
α=101.991(3)° β=97.535(3)° γ=99.847(3)°
4-Benzyl-2-[2-(4-fluorophenyl)-2-oxoethyl]-6-phenylpyridazin-3(2<i>H</i>)-one
C25H19FN2O2
Acta Crystallographica Section E (2019) 75, 7 1030-1034
a=5.0575(3)Å b=10.0973(7)Å c=38.608(2)Å
α=86.237(5)° β=86.675(5)° γ=88.354(5)°
Enzyl 1-benzyl-2-oxo-1,2-dihydroquinoline-4-carboxylate
C24H19NO3
Acta Crystallographica Section E (2019) 75, 7 980-983
a=5.6101(4)Å b=19.5523(11)Å c=17.2761(11)Å
α=90° β=96.969(5)° γ=90°
Ethyl 6-chloro-2-ethoxyquinoline-4-carboxylate
C14H14ClNO3
Acta Crystallographica Section E (2019) 75, 6 912-916
a=14.2634(7)Å b=16.0124(7)Å c=13.7732(6)Å
α=90° β=117.748(2)° γ=90°
Ethyl 2-[5-(3-chlorobenzyl)-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl]acetate
C21H19ClN2O3
Acta Crystallographica Section E (2019) 75, 6 892-895
a=8.8410(11)Å b=10.3043(12)Å c=11.3610(12)Å
α=94.801(9)° β=103.596(9)° γ=106.905(9)°
4-(2,6-Dichlorobenzyl)-6-phenylpyridazin-3(2<i>H</i>)-one
C17H12Cl2N2O
Acta Crystallographica Section E (2019) 75, 5 650-654
a=5.8511(6)Å b=12.5544(15)Å c=21.069(2)Å
α=90° β=92.666(8)° γ=90°
4-(4-Methylbenzyl)-6-phenylpyridazin-3(2<i>H</i>)-one
C18H16N2O
Acta Crystallographica Section E (2019) 75, 9 1352-1356
a=5.8479(5)Å b=8.5738(7)Å c=15.2439(12)Å
α=80.693(6)° β=83.147(7)° γ=78.164(7)°
<i>N</i>'-Diphenylmethylidene-5-methyl-1<i>H</i>-pyrazole-3-carbohydrazide
C18H16N4O
Acta Crystallographica Section E (2015) 71, 11 o890-o891
a=11.0299(2)Å b=14.1131(2)Å c=20.2211(3)Å
α=90° β=90° γ=90°
<i>N</i>'-Phenyl-<i>N</i>'-[3-(2,4,5-triphenyl-2,5-dihydro-1<i>H</i>-pyrazol-3-yl)quinoxalin-2-yl]benzohydrazide
C42H32N6O
Acta Crystallographica Section E (2013) 69, 8 o1320-o1321
a=12.0127(3)Å b=19.4679(5)Å c=15.2083(4)Å
α=90.00° β=106.0450(10)° γ=90.00°